A Study to Evaluate Safety and Efficacy of TTP273 for 12 Weeks in Subjects With Type 2 Diabetes
Open the official record
This page only displays public information reproduced from the official ClinicalTrials.gov record NCT02653599. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Parallel-Group Multi-Center Study to Evaluate the Efficacy and Safety of TTP273 Following 12 Weeks Administration in Subjects With Type 2 Diabetes Mellitus on a Stable Dose of Metformin
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This trial is a multi-center, randomized, double-blind, placebo-controlled parallel group, Phase 2 study in subjects with Type 2 diabetes mellitus on a stable dose of metformin to evaluate the safety and efficacy of TTP273 versus placebo glucose control and body weight following administration for 3 months.
Study identification
- NCT ID
- NCT02653599
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 174 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 2015 (Type not available)
- Primary completion
- Nov 2016 (Actual)
- Completion
- Jan 2017 (Actual)
- Last update posted
- Feb 10, 2017
2015 – 2017
United States locations
- U.S. sites
- 30
- U.S. states
- 12
- U.S. cities
- 28
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Costa Mesa | California | 92626 | — |
| Not listed | Encino | California | 91436 | — |
| Not listed | Huntington Park | California | 90255 | — |
| Not listed | Los Angeles | California | 90057 | — |
| Not listed | Oakland | California | 94612 | — |
| Not listed | Sacramento | California | 95821 | — |
| Not listed | DeLand | Florida | 32720 | — |
| Not listed | Miami Lakes | Florida | 33014 | — |
| Not listed | Port Orange | Florida | 32129 | — |
| Not listed | Tampa | Florida | 33606 | — |
| Not listed | West Palm Beach | Florida | 33401 | — |
| Not listed | Atlanta | Georgia | 30338 | — |
| Not listed | Evanston | Illinois | 60201 | — |
| Not listed | Flint | Michigan | 48504 | — |
| Not listed | Omaha | Nebraska | 68114 | — |
| Not listed | The Bronx | New York | 10459 | — |
| Not listed | Greensboro | North Carolina | 27408 | — |
| Not listed | High Point | North Carolina | 27265 | — |
| Not listed | Morehead City | North Carolina | 28557 | — |
| Not listed | Cincinnati | Ohio | 45246 | — |
| Not listed | Norman | Oklahoma | 73069 | — |
| Not listed | Norman | Oklahoma | 73072 | — |
| Not listed | Corpus Christi | Texas | 78413 | — |
| Not listed | Houston | Texas | 77074 | — |
| Not listed | Humble | Texas | 77338 | — |
| Not listed | Hurst | Texas | 76054 | — |
| Not listed | Katy | Texas | 77450 | — |
| Not listed | San Antonio | Texas | 78209 | — |
| Not listed | San Antonio | Texas | 78229 | — |
| Not listed | Richland | Washington | 99352 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02653599, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 10, 2017 · Synced Nov 18, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.